Policy
-
Policy Matters
Taking Steps to Address Cancer Health DisparitiesCancer outcomes are changing for the better, but advances are not affecting all patients equally.
by Brian Rivers, PhD
-
Using Leftover Cancer Drugs to Help OthersCancer drug repositories that accept unused drugs could provide an affordable source of medications for patients in need, while also providing patients left with extra drugs a way to give back.
by Jon Kelvey
-
Policy Matters
Keep Up Momentum for Medical Research FundingAdvocating for federal funds for medical research pays off when the effort is constant and compelling.
by Brandon L. Leonard, MA, and J. Tod Guidry, PhD
-
Secure ConnectionsPatients find each other online and get support they say is unparalleled, but with openness comes concern about privacy.
by Kate Yandell
-
The Coronavirus Impacts Cancer Clinical TrialsThe National Cancer Institute and the Food and Drug Administration have provided guidance for managing clinical trials amid the spread of the novel coronavirus. Cancer centers are making changes to care for some patients enrolled in trials.
by Anna Azvolinsky
-
Medicare Coverage for Next-Generation Sequencing TestsMultigene panels that rely on next-generation sequencing are increasingly used to test for hereditary cancer risk-related mutations. The federal government aims to expand Medicare coverage for these tests.
by Ashley P. Taylor
-
Forward Look
Targeted Treatments for TotsNew law mandates that cancer drugs get tested in kids in clinical trials.
by Sharon Tregaskis
-
Forward Look
Medicare to Cover CAR-T Cell TherapyHigh cost may still limit access.
by Nancy Averett
-
From the Editor-in-Chief
Value-Based Cancer Care: Paying for PerformanceThe Centers for Medicare & Medicaid Services implements incentive programs to reward quality care.
by William G. Nelson, MD, PhD
-
Forward Look
A New Use for Patient DataGregory Daniel on real-world evidence for cancer drug approvals.
by Sue Rochman
